Researchers continue to excited about the medication , a groundbreaking dual treatment showing promising results in early trials for body loss . It functions by modulating both pathways : GLP-1 and GIP, https://jasonktnt304029.fitnell.com/81816861/the-new-hope-for-body-reduction